Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00349934
Status:
COMPLETED
Last Update Posted:
2010-01-07
First Post:
2006-07-07
Brief Title:
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
Sponsor:
Immutep SAS
Organization:
Immutep SAS
Organization Data
Organization:
Immutep SAS
Class:
INDUSTRY
Study ID:
P005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Immutep SAS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
F Triebel Chief Medical Officer
Old Organization:
Immutep SA
Collaborators
| Name | Class |
|---|---|
| Umanis | INDUSTRY |